Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.

Area of Science:

• Cardiovascular disease research
• Genetics and personalized medicine
• Nutritional science

Background:

• Haptoglobin (Hp) exists in two allelic forms (Hp1 and Hp2) with differing oxidative stress protection.
• The Hp2-2 genotype is linked to lower Hp levels and elevated inflammatory markers.
• Previous research suggests vitamin E may benefit diabetes patients with the Hp2-2 genotype.

Purpose of the Study:

• To investigate the interaction between haptoglobin (Hp) polymorphism and vitamin E on mortality risk.
• To assess this interaction in individuals with and without diabetes mellitus at high cardiovascular risk.

Main Methods:

• Analysis of data from 3176 participants in the Ludwigshafen Risk and Cardiovascular Health study.
• Cox proportional hazard regression was used to analyze mortality risk.
• Evaluation of haptoglobin genotype, vitamin E (α-tocopherol and γ-tocopherol) plasma concentrations, and mortality.

Main Results:

• No direct association between Hp genotype and mortality was found.
• A borderline significant correlation between α-tocopherol and overall mortality was observed.
• A significant interaction (p=0.021) between vitamin E status and Hp genotype regarding mortality was evident, especially in diabetes patients. Hp2-2 diabetes patients showed benefit from higher γ-tocopherol.

Conclusions:

• A significant interaction between γ-tocopherol and Hp genotype on mortality exists in diabetes patients.
• Individuals with diabetes and the Hp2-2 genotype may benefit from higher γ-tocopherol levels.
• Further research is needed to understand mechanisms and therapeutic implications for cardiovascular disease management.